Dr Schubert Dean Mcphail, MD | |
401 W Decatur St, Madison, NC 27025-1913 | |
(336) 548-9618 | |
(336) 445-2227 |
Full Name | Dr Schubert Dean Mcphail |
---|---|
Gender | Male |
Speciality | Obstetrics & Gynecology - Gynecology |
Location | 401 W Decatur St, Madison, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427053008 | NPI | - | NPPES |
202289C | Other | NC | MEDICARE PTAN |
202289B | Other | NC | MEDICARE PTAN |
8958135 | Medicaid | NC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VG0400X | Obstetrics & Gynecology - Gynecology | 17591 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Schubert Dean Mcphail, MD 401 W Decatur St, Madison, NC 27025-1913 Ph: (336) 548-9618 | Dr Schubert Dean Mcphail, MD 401 W Decatur St, Madison, NC 27025-1913 Ph: (336) 548-9618 |
News Archive
Democrats, including President Barack Obama and members of Congress, have different strategies for how they will handle the spotlight on the health law next week, when it comes before the Supreme Court. House Democrats plan to celebrate the law's achievements. President Obama will be in Korea. Republicans, meanwhile, are attempting to turn it into campaign fodder.
A new study has revealed a weak spot in the complex life cycle of malaria, which could be exploited to prevent the spread of the deadly disease.
Human SH2D1A mutations resulting in X-linked lymphoproliferative syndrome type 1 are associated with a unique susceptibility to the Epstein-Barr virus, which may lead to fatal infectious mononucleosis.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere, and Hospira expects to launch the product later this month.
A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology.
› Verified 9 days ago